Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,801 | -31,752 | -276,126 | -215,676 | -145,879 |
| Depreciation Amortization | 2,748 | 1,428 | 5,621 | 2,304 | 1,309 |
| Accounts receivable | 31,686 | -1,726 | 6,113 | 40,058 | 39,714 |
| Accounts payable and accrued liabilities | 1,573 | -826 | -3,130 | -319 | -2,780 |
| Other Working Capital | -15,116 | -11,733 | 15,341 | 22,618 | 20,646 |
| Other Operating Activity | -10,347 | 14,997 | 59,204 | 8,444 | -4,235 |
| Operating Cash Flow | $-40,257 | $-29,612 | $-192,977 | $-142,571 | $-91,225 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 22,069 | 14,844 | 125,064 | 115,076 | 44,373 |
| PPE Investments | -156 | -127 | -1,198 | -1,154 | -898 |
| Investing Cash Flow | $21,913 | $14,717 | $123,866 | $113,922 | $43,475 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -460 | -227 | -947 | -732 | -524 |
| Common Stock Issued | 9,461 | 9,374 | 3,064 | 1,337 | 1,337 |
| Other Financing Activity | 14,816 | 14,994 | -107 | -107 | -107 |
| Financing Cash Flow | $23,817 | $24,141 | $2,010 | $498 | $706 |
| Beginning Cash Position | 25,987 | 25,987 | 93,088 | 93,088 | 93,088 |
| End Cash Position | 31,460 | 35,233 | 25,987 | 64,937 | 46,044 |
| Net Cash Flow | $5,473 | $9,246 | $-67,101 | $-28,151 | $-47,044 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,257 | -29,612 | -192,977 | -142,571 | -91,225 |
| Capital Expenditure | -156 | -127 | -1,223 | -1,179 | -898 |
| Free Cash Flow | -40,413 | -29,739 | -194,200 | -143,750 | -92,123 |